Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
|
BM |
Wall St Price Targets
KNSA Price Targets Summary
Kiniksa Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for KNSA is 65.43 USD with a low forecast of 57.57 USD and a high forecast of 75.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KNSA's stock price target?
Price Target
65.43
USD
According to Wall Street analysts, the average 1-year price target for KNSA is 65.43 USD with a low forecast of 57.57 USD and a high forecast of 75.6 USD.
What is the Revenue forecast for Kiniksa Pharmaceuticals Ltd?
Projected CAGR
19%
The compound annual growth rate for Revenue over the next 8 years is 19%.
What is the Gross Profit forecast for Kiniksa Pharmaceuticals Ltd?
Projected CAGR
19%
The compound annual growth rate for Gross Profit over the next 8 years is 19%.
What is the Operating Income forecast for Kiniksa Pharmaceuticals Ltd?
Projected CAGR
45%
The compound annual growth rate for Operating Income over the next 8 years is 45%.
What is the Pre-Tax Income forecast for Kiniksa Pharmaceuticals Ltd?
Projected CAGR
51%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 51%.
What is the Net Income forecast for Kiniksa Pharmaceuticals Ltd?
Projected CAGR
55%
The compound annual growth rate for Net Income over the next 8 years is 55%.
